SCHEMBL3935491

SCHEMBL3935491

N=C(N)N1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1228214 1.00
SCHEMBL11297533 1.00 F2 (1.00)
SCHEMBL11293968 1.00 F2 (1.00)
SCHEMBL11295735 1.00 F2 (1.00)
SCHEMBL821192 1.00 F2 (1.00)
SCHEMBL11288384 1.00 F2 (1.00)
SCHEMBL8281615 1.00 F2 (1.00)
SCHEMBL11295249 1.00 F2 (1.00)
Hydrochloric Acid SCHEMBL6420004 0.97 F2 (0.94)
Hydrochloric Acid SCHEMBL6422667 0.97 F2 (0.94)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101896485-A Novel compounds of reverse turn mimetics and the use thereof (3) CHOONGWAE PHARMA CORP 2010-11-24 CN claimed
CN-101827849-A Novel compounds of reverse turn mimetics and the use thereof (1) CHOONGWAE PHARMA CORP 2010-09-08 CN claimed
CN-101827850-A Novel compounds of reverse turn mimetics and the use thereof (2) CHOONGWAE PHARMA CORP 2010-09-08 CN claimed
CN-101495120-A Composition for induction or inhibition of stem cell differentiation CHOONGWAE PHARMA CORP (KR) 2009-07-29 CN claimed
CN-1942472-A Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORP (KR) 2007-04-04 CN claimed
CN-1872856-A Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORP (KR) 2006-12-06 CN claimed
CN-1872857-A Reverse-turn mimetics and method relating thereto CHOONGWAE PHARMA CORP (KR) 2006-12-06 CN claimed
CN-1871239-A Modulation of beta-catenin/tcf-activated transcription CHOONGWAE PHARMA CORP (KR) 2006-11-29 CN claimed
CN-1802378-A Beta-strand mimetics and methods relating thereto CHOONGWAE PHARMA CORP (KR) 2006-07-12 CN claimed
CN-1798746-A Reverse turn mimetics and methods relating thereto CHOONGWAE PHARMA CORP (KR) 2006-07-05 CN claimed
CN-1585770-A Reverse turn mimetics and methods relating thereto CHOONGWAE PHARMA CORP (KR) 2005-02-23 CN claimed
CN-1353701-A Peptidyl heterocyclic ketones useful as tryptase inhibitors ORTHO MCNEIL PHARM INC (US) 2002-06-12 CN claimed
US-5373008-A Phenylamidine and phenylguanidine derivatives and their use as anti-diabetic agents THE BOOTS COMPANT PLC. (GB) 1994-12-13 US claimed
EP-0536151-B1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM BOOTS CO PLC (GB) 1994-09-14 EP claimed
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 EP claimed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO claimed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 EP claimed
CN-117083065-A Novel treatment and prevention of sarcopenia-related diseases and the like 庆应义塾 2023-11-17 CN disclosed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO disclosed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 EP disclosed